Baby Eczema: What Natural Ingredients Can Help (And What to Avoid) - HOIA homespa

Free Shipping for orders over 59€ in Estonia, over 150€ in EU and over 199€ worldwide

Baby Eczema: What Natural Ingredients Can Help (And What to Avoid)

Baby eczema, or infantile atopic dermatitis, affects around 10-20% of infants in developed countries and is one of the most distressing conditions for parents to manage. The skin is visibly inflamed, itchy, and uncomfortable, and the instinct to try everything to help is understandable. But many ingredients well-intentioned parents use, including some marketed specifically for sensitive baby skin, can trigger or worsen flares. Understanding what helps and what hurts makes a real practical difference.

What’s happening in eczema skin

Atopic dermatitis involves two interconnected problems: a defective skin barrier and an overactive immune response. Mutations in the gene encoding filaggrin, a protein critical for barrier structure, are found in a significant proportion of eczema patients. Without adequate filaggrin, the skin barrier is leaky, allowing irritants, allergens, and microbes to penetrate more easily and water to escape faster.

This creates a cycle: the compromised barrier allows triggers in, triggers activate an immune response, the immune response increases inflammation and itching, scratching further damages the barrier, and the cycle continues. Managing eczema means addressing both sides: supporting the barrier and reducing inflammatory triggers.

In infants, an additional factor is the developing immune system, which is learning to distinguish harmless substances from threats. Early exposure to certain allergens through a compromised skin barrier can sensitise the immune system, increasing allergy risk. This is one reason early and effective barrier management in eczema-prone infants is considered important beyond just comfort.

What helps

Consistent emollient application is the most evidence-supported intervention for atopic dermatitis management. Regular moisturisation with an appropriate emollient reduces flare frequency, severity, and the need for topical steroids. The evidence for this is robust: multiple clinical trials support emollient therapy as the primary management approach for mild to moderate eczema.

Effective emollients for eczema-prone infant skin contain ceramides, cholesterol, and fatty acids in ratios similar to the skin’s natural lipid composition. These support the structural barrier directly. Some dermatologists specifically recommend ceramide-containing products for eczema skin rather than generic moisturisers.

Coconut oil (Cocos nucifera) is the most studied natural oil for infantile atopic dermatitis. A well-cited 2014 study in the International Journal of Dermatology found that virgin coconut oil significantly improved SCORAD (eczema severity) scores compared to mineral oil in children with atopic dermatitis. The antimicrobial properties against Staphylococcus aureus (which colonises eczema skin at high rates and worsens inflammation) are part of the mechanism.

Oat extract (colloidal oatmeal) has FDA-approved skin protectant status and multiple studies supporting its use for eczema, including in infants. It contains avenanthramides with anti-inflammatory activity and beta-glucan with hydrating and barrier-supporting properties.

Sunflower seed oil is high in linoleic acid, which is an essential fatty acid important for ceramide synthesis. A 2013 study found sunflower oil improved skin barrier function compared to olive oil in neonates.

A gentle product like HOIA’s Baby Cream uses coconut oil and natural botanicals appropriate for sensitive and eczema-prone infant skin without the irritating ingredients that can trigger flares.

What to avoid

Fragrance is the most important ingredient to eliminate completely for eczema skin. Fragrance components are among the most common contact allergens and are particularly problematic for eczema-prone skin where the compromised barrier allows deeper penetration. This applies to both synthetic fragrance and essential oils. Lavender, tea tree, citrus, and most essential oils should not be used on eczema-affected infant skin.

Olive oil sounds natural and gentle but is relatively high in oleic acid, which has been found to disrupt the skin barrier in some studies by interacting with ceramide synthesis. A 2013 study in Pediatric Dermatology found olive oil increased transepidermal water loss compared to no oil in neonates. This doesn’t mean olive oil is always harmful, but it’s not the first choice for eczema-prone infant skin.

Preservatives are worth scrutinising. Methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) are sensitisers that have been restricted or banned in leave-on EU cosmetics but still appear in some products. Formaldehyde-releasing preservatives should also be avoided for eczema skin.

Bubble bath and foaming products typically contain surfactants that strip the skin barrier. Baths themselves are helpful for eczema (they hydrate the skin), but the products used in them shouldn’t strip what the water adds. Plain water baths or a tiny amount of mild non-foaming cleanser are appropriate for eczema flares.

Practical bath and moisturise routine

Lukewarm (not hot) baths for 5-10 minutes help hydrate the skin. Hot water aggravates eczema by triggering mast cell degranulation and the itch response. Daily bathing is fine and helpful when followed immediately by emollient application.

Pat dry very gently without rubbing. Apply emollient within three minutes of bath. The “soak and seal” principle, bathing to hydrate and then immediately sealing with emollient, is one of the most consistently recommended approaches in eczema management guidance.

Apply emollient liberally and frequently, not just after bathing. For actively flaring eczema, applying two to three times daily is often recommended. During remission, once daily is usually adequate to maintain the barrier.

When to involve a doctor

Topical steroids prescribed by a doctor are an appropriate and sometimes necessary part of eczema management for inflamed flares. There is significant parent anxiety about steroid use in infants, but the risk of under-treating active inflammation (which increases sensitisation risk and causes significant distress) is greater than the risk of appropriate steroid use at the lowest effective strength for the minimum time required. Discuss this with your paediatrician or GP rather than avoiding steroids entirely based on general concern.

If eczema is severe, widespread, or not responding to emollient therapy, referral to a paediatric dermatologist is appropriate. Wet wrap therapy and other specialist approaches can be very effective for severe cases.